HCV–Related Mixed Cryoglobulinemia: Data from Piter, a Nationwide Italian HCV Cohort StudyLoreta A. Kondili, Salvatore Petta, L. Surace et al.|Journal of Hepatology|2016Cited by 5
602 THE CANDIDATE HCV E1E2MF59 VACCINE IS SAFE IN CHRONIC HEPATITIS C PATIENTS AND ACCELLERATES THE SECOND PHASE VIRAL DECLINE UPON PRIMARY RESPONSE TO PEG-INTERFERON-2A/RIBAVIRIN THERAPYP. Colombatto, Ferruccio Bonino, Maurizia Rossana Brunetto et al.|Journal of Hepatology|2009Cited by 1
Diagnostic and therapeutic approaches of mixed cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohortLoreta A. Kondili, Anna Linda Zignego, Monica Monti et al.|Journal of Hepatology|2017Cited by 1
HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort studyLiliana Elena Weimer, O. Patti, M. Vinci et al.|Digestive and Liver Disease|2016Cited by 1